Showing results (61-70 of 93) with videos related to
Sort By:
Pageof 10
Cell Death & Disease|June 14, 2019
miR-21 promotes NLRP3 inflammasome activation to mediate pyroptosis and endotoxic shockZhenyi Xue, Qing Xi, Hongkun Liu, et al.Molecular Neurobiology|August 13, 2016
Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt PathwayKai Zhang, Yawei Guo, Zhenzhen Ge, et al.Frontiers in Oncology|November 4, 2021
ARV-825 Demonstrates Antitumor Activity in Gastric Cancer via MYC-Targets and G2M-Checkpoint Signaling PathwaysXinmei Liao, Xiaoqing Qian, Zimu Zhang, et al.Carcinogenesis|February 1, 2024
The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genesJuanjuan Yu, Yang Yang, Rongfang Zhou, et al.Cancer Cell International|February 21, 2024
Super enhancer related gene ANP32B promotes the proliferation of acute myeloid leukemia by enhancing MYC through histone acetylationXiaomei Wan, Jianwei Wang, Fang Fang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 2, 2026
NUDT21 Drives T-Cell Acute Lymphoblastic Leukemia Through Dual Regulation of Alternative Polyadenylation and Transcriptional ActivationConglian Qiu, Jianwei Wang, Zhiheng Li, et al.Nature Communications|July 15, 2021
Loss of fragile site-associated tumor suppressor promotes antitumor immunity via macrophage polarizationLijuan Zhang, Kai Zhang, Jieyou Zhang, et al.Autophagy|September 14, 2018
Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1Yan Li, Dongmei Zhou, Yinghui Ren, et al.BMC Cancer|February 16, 2024
MZ1, a BRD4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastomaGen Li, Liya Ma, Chenxi Feng, et al.Pathology Oncology Research : POR|July 14, 2022
A Novel BRD Family PROTAC Inhibitor dBET1 Exerts Great Anti-Cancer Effects by Targeting c-MYC in Acute Myeloid Leukemia CellsKunlong Zhang, Li Gao, Jianwei Wang, et al.Pageof 10